Journal List > J Korean Ophthalmol Soc > v.51(2) > 1008725

Choi and Choi: Accuracy of Intraocular Lens Power Calculation in Diabetic Patients

Abstract

Purpose

To assess the refractive outcome of cataract surgery employing IOL master and A-scans in diabetic and non-diabetic patients

Methods

The retrospective comparative study included 205 eyes of consecutive patients who had uneventful cataract surgery implanting I-Flex IOL. Axial length was measured with IOL master and A-scan and IOL power was calculated using various formulas (SRK II, SRK/T, Haigis, Holladay). Subjects was separated into five groups according to axial length, and then the groups were divided into diabetic and non-diabetic subgroups. Differences between the predicted refraction and the actual refraction were compared and analyzed at two months after the operation.

Results

The mean absolute errors (MAE) of ten groups showed no significant differences. Comparing diabetic groups and non-diabetic groups, there were no statistically significant differences. Also the result of the two modalities, IOL master and A-scan, were not different in statistical analysis.

Conclusions

In diabetic and non-diabetic patients, IOL master and A-scan may be the accurate methods for calculating IOL power regardless of the axial length.

References

1. Elkady B, Alio JL, Oritz D, Montalban R. Corneal aberrations after microincision cataract surgery. J Cataract Refract Surg. 2008; 34:40–5.
crossref
2. Marcos S, Rosales P, Llorente L, Jimenez-Alfaro I. Change in corneal aberrations after cataract surgery with 2 types of aspherical intraocular lenses. J Cataract Refract Surg. 2007; 33:217–26.
crossref
3. Drexler W, Findle O, Menapace R, et al. Partial coherence aberrations: a novel approach to biometry in cataract surgery. Am J Ophthalmol. 1998; 126:524–34.
4. Connors R 3rd, Bosenal P 3rd, Olson RJ. Accuracy and aberrations using partial coherence interferometry. J Cataract Refract Surg. 2002; 28:235–8.
5. Rajan MS, Kelihorn I, Bell JA. Partial coherence laser aberrations vs conventional ultrasound biometry in intraocular lens power calculations. Eye. 2002; 16:5552–6.
6. Findle O, Drexler W, Menapace R, et al. Improved prediction of intraocular lens power using partial coherence interferometry. J Cataract Refract Surg. 2001; 27:861–7.
7. Mitchell P, Smith W, Chey T, Healey PR. Open angle glaucoma and diabetes: the Blue mountains Eye study, Australia. aberrations. 1997; 104:712–8.
8. Dyck PJ, Lais A, Karnes JL, et al. Fiber loss is primary and aberrations in sural nerves in diabetic polyneuropathy. Ann Neurol. 1986; 19:425–39.
9. Hasemyer S, Hugger P, Jones JB. Preoperative biometry of aberrations eyes with using partial coherence laser interferometry. aberrations Arch Clin Exp Ophthalmol. 2003; 21:251–2.
10. Chung JK, Choe CM, You YS, et al. Biometry with partial aberrations interferometry and ultrasonography in high myopes. J Korean Ophthalmol Soc. 2006; 47:355–61.
11. Lee JT, Song JS, Kim HM. The accuracy of axial length aberrations using partial coherence interferometry. J Korean aberrations Soc. 2003; 44:812–7.
12. Olsen T. Sources of error in intraocular lens power calculation. J Cataract Refract Surg. 1992; 18:125–9.
crossref
13. Choi JH, Roh GW. The reproducibility and accuracy of biometry parameter measurement from IOL Master®. J Korean aberrations Soc. 2004; 45:1665–73.
14. Nemeth J, Fekete O, Pesztenlehrer N. Optical and ultrasound measurement of axial length and anterior chamber depth for aberrations lens power Calculation. J cataract Refract Surg. 2003; 29:85–8.
15. Lam AK, Chan R, Pang PC. The repeatability and accuracy of axial length and anterior chamber depth measurements from the IOL master. Ophthalmic Physiol Opt. 2001; 21:477–83.
16. Drexler W, Hitzenberger CK, Baumgartner A, et al. Investigation of dispersion effects in ocular media by multiple wavelength partial coherence interferometry. Exp Eye Res. 1998; 66:25–33.
crossref
17. Fercher AR, Hitzenberger CK, Drexler W, et al. In vivo optical coherence tomography. Am J Ophthalmol. 1993; 116:113–4.
crossref
18. Rose LT, Moshegov CN. Comparison of the Zeiss IOL Master and applanation A-scan ultrasound: biometry for intraocular lens calculation. Clin Experiment Ophthalmol. 2003; 31:121–4.
19. Eleftheriadis H. IOL Master biometry: refractive results of 100 consecutive cases. Br J Ophthalmol. 2003; 87:960–3.
20. Packer M, Fine IH, Hoffman RS, et al. Immersion A-scan aberrations with partial coherence interferometry: outcomes analysis. J Cataract Refract Surg. 2002; 28:239–42.
21. Song BY, Yang KJ, Yoon KC. Accuracy of partial coherence aberrations in intraocular lens power calculation. J Korean aberrations Soc. 2005; 46:775–80.
22. Hwang JS, Lee JH. Comparison of the IOL master and A-scan ultrasound: Results of 96 Consecutive Cases. J Korean aberrations Soc. 2007; 48:27–32.
23. Wang JK, Hu CY, Chang SW. Intraocular lens power calculation using the IOL Master and various formulas in eyes with long axial length. J Cataract Refract Surg. 2008; 34:262–7.
24. Rajan MS. Kelihorn I, Bell JA. Partial coherence laser aberrations vs conventional ultrasound biometry in intraocular ocular lens power calculation. Eye. 2002; 16:552–6.

Table 1.
Characteristics of each group according to the axial length
Group Diabetes A B C Total
N yes 3 54 7 64 205
no 2 128 11 141
Sex(M/F) yes 1/2 49/5 6/1 56/8 167/38
no 2/0 103/25 6/5 111/30
Right/Left yes 2/1 32/22 4/3 38/26 104/101
no 1/1 60/68 5/6 66/75
Age (years) yes 77.67±5.03 70.10±5.24 65.71±6.87 70.27±7.31 73.27±6.80
no 70.50±9.19 74.67±5.37 74.82±8.05 74.63±6.11
Axial length (mm) yes 21.90±0.14 23.87±0.35 25.97±0.70 23.80±1.08 23.66±0.97
(21.74–21.98) (22.00–24.74) (25.18–27.04) (21.74–27.04)
no 21.75±0.35 23.53±0.26 25.52±0.41 23.60±0.92
(21.50–21.99) (22.15–24.86) (25.07–26.10) (21.50–26.10)

A: Group A, axial length <22 mm; B: Group B, axial length ≥22, <25 mm; C: Group C, axial length ≥25 mm.

Table 2.
Comparison of various IOL power calculation formulas installed in IOL Master
Group (Axial length, mm) Diabetes Eyes Mean Absolute Difference, Predicted vs Actual Postop SE(Diopter)
p-value
MAEhd MAEs2 MAEst MAEhg MAEas Total
Group A1 (<22) yes 3 0.54±0.49 0.9910
 Mean± SD 0.73±0.81 0.97±0.75 0.94±0.71 0.70±0.76 0.71±0.75 0.81±0.75 (0.07–1.25) (0.2125)§
 Range 0.15–1.43 0.20–1.70 0.16–1.55 0.13–1.35 0.00–1.50 0.02–1.51*
Group A2 (<22) no 2
 Mean± SD 0.38±0.22 0.29±0.19 0.34±0.22 0.40±0.26 0.26±0.94 0.33±0.37
 Range 0.23–0.54 0.15–0.43 0.18–0.50 0.22–0.59 0.41–0.93 0.07–0.59
Group B1 (≥22, <25) yes 54 0.83±1.92 0.9772
 Mean± SD 1.52±1.24 1.53±1.249 1.24±1.35 1.12±1.45 1.01±1.37 1.53±1.17 (1.53–8.92) (0.8482)
 Range 0.49–8.21 0.45–8.48 0.48–8.48 0.54–8.36 0.38–8.38 0.32–8.54
Group B2 (≥22, <25) no 128
 Mean± SD 2.37±1.80 2.14±1.75 2.54±1.90 2.52±1.85 2.32±1.00 2.38±1.54
 Range 2.61–9.49 2.60–9.50 2.63–9.47 2.33–9.47 2.50–9.50 2.67–9.68
Group C1 (≥23, <24) yes 25 0.48±1.74 0.9582
 Mean± SD 0.17±1.13 0.16±1.11 0.17±1.12 0.17±1.14 0.03±1.10 0.13±1.11 (7.17–8.92) (0.9037)
 Range 1.61–4.28 1.40–4.25 1.61–4.28 1.50–4.33 1.38–4.25 1.48–4.28
Group C2 (≥23, <24) no 50
 Mean± SD 0.78±2.53 0.82±2.55 0.82±2.52 0.80±2.53 0.65±2.64 0.77±2.55
 Range 9.01–11.16 9.10–11.15 8.87–11.15 8.98–11.16 9.81–11.25 9.15–11.17
Total yes 64 0.66±2.12 0.6290
 Mean± SD 0.80±1.70 0.80±1.73 0.82±1.71 0.79±1.73 0.63±1.76 0.65±1.37 (7.17–8.92)
 Range 4.28–8.21 4.25–8.48 4.28–8.48 4.33–8.36 4.25–8.38 3.42–6.93
Total no 141
 Mean± SD 0.63±2.28 0.64±2.29 0.65±2.28 0.65±2.28 0.49±2.34 0.52±1.82
 Range 9.01–11.16 9.10–11.15 8.90–11.15 8.98–11.16 9.81–11.25 7.17–8.92
Total 205 0.9170
 Mean± SD 0.68±2.11 0.69±2.13 0.70±2.12 0.69±2.12 0.53±2.17 0.66±2.12
 Range 9.01–11.16 9.10–11.15 8.90–11.15 8.98–11.16 9.81–11.25 (9.15–11.17)
p-value 0.8809 0.9375 0.9103 0.8688 0.8884 0.8988

MSE=mean spherical equivalent; SD=standard deviation; Kruskal-Wallis test

* Group A1 vs Group A2: p=0.7429

Group B1 vs Group B2: p=0.3784

Group C1 vs Group C2: p=0.5512

§ Group A (IOL Master® vs A-scan): p=0.2125

Group B (IOL Master® vs A-scan): p=0.8482

Group C (IOL Master® vs A-scan): p=0.9037 (Mann-Whitney U test).

Table 3.
Comparison of various IOL power calculation formulas installed in IOL Master
Group (Axial length, mm) Formula Percentage of eyes within 0.50D, 1.00 D, and 1.50 D from intended refraction.
≤0.50 D ≤1.00 D ≤1.50 D
Group A (<22) MAEhd 100% 100% 100%
MAEs2 100% 100% 100%
MAEst 100% 100% 100%
MAEhg 100% 100% 100%
MAEas 100% 100% 100%
Group B (≥22, <25) MAEhd 93.76% 100% 100%
MAEs2 93.76% 100% 100%
MAEst 93.76% 100% 100%
MAEhg 90.71% 100% 100%
MAEas 90.24% 98.25% 100%
Group C (≥25) MAEhd 88.89% 94.44% 100%
MAEs2 88.89% 94.44% 100%
MAEst 88.89% 94.44% 100%
MAEhg 88.89% 94.44% 100%
MAEas 83.33% 94.44% 100%
Table 4.
Comparison of various IOL power calculation formulas installed in IOL Master
Group (Axial length, mm) Formula Over 0.50 D Myopia*(≥0.50 D) Over 1.00 D Myopia(≥1.00 D) Over 0.50 D Hyperopia(≥0.50 D) Over 1.00 D Hyperopia§(≥1.00 D)
Group A (<22) MAEhd 0% 0% 0% 0%
MAEs2 0% 0% 0% 0%
MAEst 0% 0% 0% 0%
MAEhg 0% 0% 0% 0%
MAEas 0% 0% 0% 0%
Group B (≥22, <25) MAEhd 2.19% 1.02% 25.24% 18.84%
MAEs2 2.19% 1.02% 25.24% 14.82%
MAEst 2.19% 1.02% 29.87% 16.54%
MAEhg 2.21% 1.02% 29.87% 14.82%
MAEas 4.65% 1.54% 55.37% 28.52%
Group C (≥25) MAEhd 14.28% 7.14% 0% 0%
MAEs2 14.28% 7.14% 0% 0%
MAEst 14.28% 7.14% 0% 0%
MAEhg 14.28% 7.14% 0% 0%
MAEas 14.28% 7.14% 25.00% 0%

* Percentage of eye which was myopic shift over 0.50 D from intended refraction

Percentage of eye which was myopic shift over 1.00 D from intended refraction

Percentage of eye which was hyperopic shift over 0.50 D from intended refraction

§ Percentage of eye which was hyperopic shift over 1.00 D from intended refraction.

TOOLS
Similar articles